Mytide Therapeutics
Boston, US · Founded 2017 · Delaware corporation
Biotech
Founders & leadership
JN
Jason NorrisMr. Norris is the Treasurer and Secretary of the Issuer.
EA
Errik AndersonDirector
DT
Dale ThomasMr. Thomas is the President of the Issuer.
Reported raises · per SEC filings
Form D private placements▶$1.2MraisedJan 2023 · 9 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Errik AndersonDirector
- Jason NorrisExecutive Officer, Director, Promoter
- Dale ThomasExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $1.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.1MraisedJun 2022 · 23 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Jason NorrisExecutive Officer, Director, Promoter
- Errik AndersonDirector
- Dale ThomasExecutive Officer, Director, Promoter
- Offering amount
- $7.1M
- Amount sold
- $7.1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.